US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Profound Medical Corp.

< Previous 1 2 3 Next >
News headline image
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Reports Strong Third Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Participate in the Stifel 2025 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Second Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces First Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical AUA 2025 Investor Event Agenda
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Save the Date: Profound Medical to Host Investor Event at AUA 2025
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
News headline image
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
< Previous 1 2 3 Next >